Suppr超能文献

含吲哚美辛白蛋白-壳聚糖微球的水性制剂及其评价

Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.

作者信息

Bayomi Mohsen A

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

出版信息

Drug Dev Ind Pharm. 2004 Apr;30(4):329-39. doi: 10.1081/ddc-120030425.

Abstract

Controlled-release egg albumin-chitosan microspheres containing indomethacin as a model drug were successfully prepared by coacervation method. The proposed method can offer a simple method for microsphere preparation in an aqueous system with the elimination of the use of organic solvents that are usually needed in conventional techniques of microencapsulation. The interaction between negatively charged egg albumin molecules in phosphate buffer, pH 7.2, or sodium hydroxide solution and positively charged chitosan molecules dissolved in diluted acetic acid to form an insoluble precipitate was the principle for the formation of the microspheres. The effects of many process variables, such as amount of formaldehyde as a cross-linking agent, stirring time, final pH of encapsulation medium, initial drug loading, and albumin concentration or albumin-to-chitosan weight ratio, on the properties of the prepared microspheres were investigated. Incorporation efficiencies of the microspheres to the drug were high in most cases and ranged between 63.3 +/- 3.6% and 92.39 +/- 3.2%, while particle sizes were 435.2 +/- 12.6 up to 693.9 +/- 34.6 microm for the different tested batches. On the other hand, the values of angles of repose and compressibility indices were in the range of 23.5 +/- 0.4 to 32.0 +/- 0.7 degrees and 11.1 +/- 0.7% to 23.6 +/- 0.7% respectively, which indicate overall good free flowing nature of the microspheres of all batches. The maximum required amount of the cross-linking agent was determined to avoid excessive unnecessary chemicals. It was also noticed that excessive time of stirring and excessive initial drug loading are not recommended as it may lead to microspheres of low properties. The pH of the encapsulation media (pH 3.77 up to pH 4.91) significantly affected the properties of the microspheres. As the pH of the encapsulation media was increased, the incorporation efficiency, particle size, and flowability decreased, along with increase of drug release rate, which could be related to incomplete cross linking of the microspheres matrix. It was also observed that high concentration of albumin solution and accordingly the increase of albumin-to-chitosan weight ratio were accompanied with increases in incorporation efficiency and particle size with improved microsphere flowability and slow indomethacin release. Thus, the proposed microspheres showed the ability to control the release of indomethacin, and their properties were highly affected by many process variables that could be controlled to obtain an optimized system.

摘要

以吲哚美辛为模型药物,通过凝聚法成功制备了控释卵清蛋白 - 壳聚糖微球。所提出的方法可为水相体系中的微球制备提供一种简单方法,避免了传统微囊化技术中通常所需的有机溶剂的使用。在pH 7.2的磷酸盐缓冲液或氢氧化钠溶液中带负电荷的卵清蛋白分子与溶解在稀释乙酸中的带正电荷的壳聚糖分子之间相互作用形成不溶性沉淀,这是微球形成的原理。研究了许多工艺变量,如交联剂甲醛用量、搅拌时间、包封介质的最终pH值、初始载药量以及白蛋白浓度或白蛋白与壳聚糖的重量比等对所制备微球性质的影响。大多数情况下,微球对药物的包封率较高,在63.3±3.6%至92.39±3.2%之间,而不同测试批次的粒径在435.2±12.6至693.9±34.6微米之间。另一方面,休止角和压缩性指数的值分别在23.5±0.4至32.0±0.7度和11.1±0.7%至23.6±0.7%范围内,这表明所有批次微球的总体自由流动性质良好。确定了交联剂的最大需求量,以避免过多不必要的化学物质。还注意到不建议搅拌时间过长和初始载药量过高,因为这可能导致微球性能不佳。包封介质的pH值(pH 3.77至pH 4.91)对微球的性质有显著影响。随着包封介质pH值的升高,包封率、粒径和流动性降低,同时药物释放速率增加,这可能与微球基质的交联不完全有关。还观察到高浓度的白蛋白溶液以及相应的白蛋白与壳聚糖重量比的增加伴随着包封率和粒径的增加,微球流动性得到改善,吲哚美辛释放缓慢。因此,所提出的微球显示出控制吲哚美辛释放的能力,其性质受到许多工艺变量的高度影响,这些变量可以进行控制以获得优化体系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验